Habil F Khorakiwala, founder, chairman and group CEO of Wockhardt says the company has replied to US food and drug administration (FDA) on issues related to its L1, Waluj and Shendra facilities and although a few issues are pending, he hopes it will be resolved soon
first published: Feb 16, 2016 12:39 pm
A collection of the most-viewed Moneycontrol videos.
FSS Simply Payments 2025 | AI in Payments: Building a Governance-First Future.
Live: Nifty reclaims 25,900, snaps 3-day losing streak; rupee falls to fresh low | Closing Bell
Live: Can Nifty snap 3-day losing streak after Fed's policy outcome? | Opening Bell
Live: Nifty slips below 24,800 as breadth weakens; SMIDs underperform | Closing Bell
